Development of a machine learning model to predict risk of development of COVID-19-associated mucormycosis

被引:1
|
作者
Patil, Rajashri [1 ]
Mukhida, Sahjid [1 ]
Ajagunde, Jyoti [1 ]
Khan, Uzair [1 ]
Khan, Sameena [1 ]
Gandham, Nageswari [1 ]
Vyawhare, Chanda [1 ]
Das, Nikunja K. [1 ]
Mirza, Shahzad [1 ]
机构
[1] Dr DY Patil Vidyapeeth, Dr DY Patil Med Coll Hosp & Res Ctr, Dept Microbiol, Pune 18, India
关键词
COVID-19-associated mucormycosis; machine learning; mucormycosis; rhino-orbito-cerebral mucormycosis;
D O I
10.2217/fmb-2023-0190
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Aim: The study aimed to identify quantitative parameters that increase the risk of rhino-orbito-cerebral mucormycosis, and subsequently developed a machine learning model that can anticipate susceptibility to developing this condition. Methods: Clinicopathological data from 124 patients were used to quantify their association with COVID-19-associated mucormycosis (CAM) and subsequently develop a machine learning model to predict its likelihood. Results: Diabetes mellitus, noninvasive ventilation and hypertension were found to have statistically significant associations with radiologically confirmed CAM cases. Conclusion: Machine learning models can be used to accurately predict the likelihood of development of CAM, and this methodology can be used in creating prediction algorithms of a wide variety of infections and complications. Fungal infections caused by the Mucorales order of fungi usually target patients with a weakened immune system. They are usually also associated with abnormal blood sugar states, such as in diabetic patients. Recent work during the COVID-19 outbreak suggested that excessive steroid use and diabetes may be behind the rise in fungal infections caused by Mucorales, known as mucormycosis, in India, but little work has been done to see whether we can predict the risk of mucormycosis. This study found that these fungal infections need not necessarily be caused by Mucorales species, but by a wide variety of fungi that target patients with weak immune systems. Secondly, we found that diabetes, breathing-assisting devices and high blood pressure states had associations with COVID-19-associated fungal infections. Finally, we were able to develop a machine learning model that showed high accuracy when predicting the risk of development of these fungal infections.
引用
收藏
页码:297 / 305
页数:9
相关论文
共 50 条
  • [31] Concurrent plexiform ameloblastoma and COVID-19-associated mucormycosis of the maxilla
    Ingle, Yashwant
    Sarode, Sachin C.
    Sarode, Gargi
    Ingle, Manjusha
    Ingle, Sanyukta
    ORAL ONCOLOGY, 2022, 125
  • [32] Covid-19-Associated Mucormycosis: Histopathology of the Deadly Fungal Infection
    Anand, Nidhi
    Srivastava, Pallavi
    Agrawal, Ashish Chandra
    Gupta, Nikhil
    Das, Anupam
    Husain, Nuzhat
    INTERNATIONAL ARCHIVES OF OTORHINOLARYNGOLOGY, 2024, 28 (02) : e240 - e246
  • [33] A case of COVID-19-associated mucormycosis due to Lichtheimia ramosa
    Aboutalebian, Shima
    Erami, Mahzad
    Momen-Heravi, Mansooreh
    Charsizadeh, Arezoo
    Hezaveh, Seyed Jamal Hashemi
    Matini, Amir Hassan
    Ahsaniarani, Amir Hossein
    Fakhrehi, Mojtaba
    Mirhendi, Hossein
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (08)
  • [34] COVID-19-associated Mucormycosis: A clinico-epidemiological study
    Chakravarty, Jaya
    Gupta, Munesh Kumar
    Tilak, Ragini
    Kumar, Rajesh
    Maurya, Rajendra Prakash
    Kumar, Nilesh
    Aggarwal, Susheel Kumar
    Shiva, S.
    Sharma, Naresh Kumar
    Dhiman, Neeraj Kumar
    Chaubey, Manaswi
    Singh, Vishambhar
    Verma, Ashish
    Banerjee, Tuhina
    Agrawal, Neeraj Kumar
    Prasad, Ravi Shankar
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2022, 36 (09)
  • [35] Be vigilant in treating a patient with diabetes and COVID-19-associated mucormycosis
    Thangaraju, Pugazhenthan
    Velmurugan, Hemasri
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2023, 12 (08) : 1740 - 1741
  • [36] COVID-19-associated disseminated mucormycosis: An autopsy case report
    Kyuno, Daisuke
    Kubo, Terufumi
    Tsujiwaki, Mitsuhiro
    Sugita, Shintaro
    Hosaka, Michiko
    Ito, Hazuki
    Harada, Keisuke
    Takasawa, Akira
    Kubota, Yusaku
    Takasawa, Kumi
    Ono, Yusuke
    Magara, Kazufumi
    Narimatsu, Eichi
    Hasegawa, Tadashi
    Osanai, Makoto
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (28) : 10358 - 10365
  • [37] Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19
    Sharma, Neelam
    Wani, Shahid Nazir
    Behl, Tapan
    Singh, Sukhbir
    Zahoor, Ishrat
    Sehgal, Aayush
    Bhatia, Saurabh
    Al-Harrasi, Ahmed
    Aleya, Lotfi
    Bungau, Simona
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2023, 30 (04) : 9164 - 9183
  • [38] COVID-19-Associated Mucormycosis: What Neurologists Should Know?
    Kulkarni, Rahul
    Pujari, Shripad
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2022, 25 (03) : 330 - 331
  • [39] COVID-19-associated mucormycosis: an epidemic within a pandemic COMMENT
    Sarda, R.
    Swain, S.
    Ray, A.
    Wig, Naveet
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2021, 114 (06) : 355 - 356
  • [40] Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19
    Neelam Sharma
    Shahid Nazir Wani
    Tapan Behl
    Sukhbir Singh
    Ishrat Zahoor
    Aayush Sehgal
    Saurabh Bhatia
    Ahmed Al-Harrasi
    Lotfi Aleya
    Simona Bungau
    Environmental Science and Pollution Research, 2023, 30 : 9164 - 9183